Research Progress of DUB Enzyme in Hepatocellular Carcinoma
According to GLOBOCAN 2021 cancer incidence and mortality statistics compiled by the International Agency for Research on Cancer, hepatocellular carcinoma (HCC) is the most common malignancy in the human liver and one of the leading causes of cancer death worldwide.Although there have been great advances in the treatment of HCC, such as regofenib,